Samik Kumar Bandyopadhyay

Tiny crystals 💍. Big inflammation 🔥. Human biopsies ✅ Macrophage data ✅ Mouse model ✅ A mechanistic breakthrough for a poorly understood condition. @my_ueg @UEGJournal @JuliaMayerle @SimonSirtl 👏👏 📄 doi.org/10.1002/ueg2.7…

Rethinking Optimal Therapy for Operable Pancreatic Cancer in the CASSANDRA Era. Co-authored by @faupe. Read the full article. bit.ly/4rlyzAh #pancsm

In a Delphi consensus, hepatobiliary surgeons established a standardized definition of “extreme liver surgery” to improve consistency in managing complex hepatic disease and outline principles for patient selection and operative strategy. journals.lww.com/annalsofsurger…

Changing treatment outcomes in metastatic and recurrent pancreatic cancer: a real-world comparison before and after the availability of nanoliposomal irinotecan | Japanese Journal of Clinical Oncology | Oxford Academic academic.oup.com/jjco/article/5…

Research reveals a new mechanism for lenvatinib resistance in hepatocellular carcinoma.💊 Exosomal miRNA-132 from resistant cells can transfer resistance to naive cells via the PTEN/GSK3β/Nrf2 pathway, identifying a potential new therapeutic target to overcome chemoresistance.📈 onlinelibrary.wiley.com/doi/10.1002/ag… #AGSurg

Cancer is a whole-body disease nature.com/articles/d4247…

Liver resection for non colorectal mets 🫧 biology biology biology! 🧬 Survival depends on indication 🦓 NET and GIST after TKI best ✋ Pancreas and UpperGI ONLY in extremely selected oligo and liver-only #fig0005" target="_blank" rel="nofollow noopener">sciencedirect.com/science/articl…

KRAShing pancreatic cancer before takeoff ⁦@ScienceMagazine⁩ science.org/doi/10.1126/sc…

KRAS inhibitors have been used to treat pancreatic cancer, but can they PREVENT cancer from occurring altogether? In @ScienceMagazine from @PennCancer Cancer interception with KRAS inhibitors in preclinical models of #PancreaticCancer science.org/doi/10.1126/sc…

Glad 👍🏽to see this aggressive approach for #cholangiocarcinoma is being studied by the experienced group from Oslo 🇳🇴 #transplantoncology @curecc @ASTSChimera @IHPBA @OHSUKnight #GiveCancerHell

A Novel Transplant Approach for Locally Advanced... : Annals of Surgery journals.lww.com/annalsofsurger…

@Andrew007Uk @vfleming71 Happy birthday..,, have a great year ahead

Another year around the Sun complete. Done that journey 57 times now! Thanks to all made it special in different ways, especially my rock, @vfleming71 ❤️

@RameshSinghBh12 @IHPBA @_ILTS_ I remember my days at UCMS Bhairahawa fondly…, had taken associate membership of SSN while there 25 years ago..,

Very excited to deliver this talk at Birat Medical College and Teaching Hospital, Biratnagar @IHPBA @_ILTS_

🦓 #NETs fireside chat with @AGangiMD & @RupenShahMD for @AHPBA now available🎥 Decision-making in pancreas NETs and liver metastases 🤔 & some 🔑 advice for early-career surgeons interested in NETs Worth a watch: youtube.com/watch?v=dS6c3s…

Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL) @JHepatology doi.org/10.1016/j.jhep… 👉Proof of concept study 👉Implementing immunotherapy before LTx is feasible @myESMO @ASCO @EASLnews

💫Highlights from the @hpbjournal: 🧵 Pancreatic tail anatomy & spleen preservation in robotic LSP 🤖🫀 📊 46 robotic left-sided pancreatectomies with intended spleen preservation 🧠 Pancreatic tail classified into 4 anatomical types (I–IV) 🔍 Key results: • Type IV anatomy strongly associated with spleen preservation failure • Type III/IV → lower spleen preservation (52% vs 91%) • Larger tumors, more blood loss & longer operative time 🎯 Take-home: Preoperative pancreatic tail classification matters. hpbonline.org/article/S1365-…

Cyst fluid next-generation sequencing provides high sensitivity and specificity for detecting advanced neoplasia in mixed-type IPMNs, supporting its use in risk stratification. ja.ma/4kh7dJT

@HalletJulie @SocSurgOnc @PatricioPolanc0 @HoggNDMD @FlavioRochaMD @ColinCourtMD @globalsurgallie @AGangiMD @DrCNClarke @Gio_Marchegiani @ZhiVenFongMD @isteaus Thanks for getting back.., will be grateful if recordings are available… will wait for the next programme as well.. Regards

@SamikKumarBand1 @SocSurgOnc @PatricioPolanc0 @HoggNDMD @FlavioRochaMD @ColinCourtMD @globalsurgallie @AGangiMD @DrCNClarke @Gio_Marchegiani @ZhiVenFongMD @isteaus Thanks for the interest! It's only in-person meeting unfortunately.

#SSO2026 is just 10 days away! 🌵 Join us in Phoenix - a strong HPB & GI program with liver, pancreas, NETs, and translational oncology. Don't miss the sessions 👇🏻 Lots to learn, discuss, and debate @SocSurgOnc! See you there!